title: Comparison of risk profile and clinical outcome of patients after acute pulmonary embolism in university and non-university hospitals.
authors.forename: W
authors.initials: W
authors.lastname: Zondag
authors.forename: F A
authors.initials: FA
authors.lastname: Klok
authors.forename: M
authors.initials: M
authors.lastname: Nijkeuter
authors.forename: M
authors.initials: M
authors.lastname: Kruip
authors.forename: R A
authors.initials: RA
authors.lastname: Douma
authors.forename: M H H
authors.initials: MH
authors.lastname: Kramer
authors.forename: M V
authors.initials: MV
authors.lastname: Huisman
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D015897:Comorbidity; D005260:Female; D006470:Hemorrhage / Q000209:etiology; D006785:Hospitals, University / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009426:Netherlands / Q000453:epidemiology; D016017:Odds Ratio; D010690:Phlebography; D011655:Pulmonary Embolism / Q000175:diagnosis* / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D012008:Recurrence; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D036542:Tomography, Spiral Computed; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000150:complications / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*
chemical_list: D000925:Anticoagulants